Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec;10(12):2658-64.
doi: 10.1111/j.1600-6143.2010.03326.x. Epub 2010 Nov 18.

Height contributes to the gender difference in wait-list mortality under the MELD-based liver allocation system

J C Lai  1 , N A Terrault, E Vittinghoff, S W Biggins
Affiliations

Height contributes to the gender difference in wait-list mortality under the MELD-based liver allocation system

J C Lai et al. Am J Transplant. 2010 Dec.

Abstract

This study examined factors associated with the gender disparity in wait-list mortality in the MELD era. Adult patients listed for liver transplantation from 2002 to 2008 were included. Females [12 585(36%)] and males [22 126(64%)] differed clinically by age (54 vs. 52 years), height (1.6 vs. 1.8 m), listing estimated glomerular filtration rate [(eGFR); 70 vs. 83 mL/min] and cirrhosis etiology. Holding MELD constant, females were at 19% (95% CI, 1.13-1.25, p < 0.001) higher risk of wait-list mortality than males under the current allocation system. The relative hazard increased with worsening renal function, whether measured by serum creatinine or eGFR. Adjustment for MELD, age, African-American race, cirrhosis etiology, region and ABO group attenuated this relative hazard (HR 1.16; 95% CI, 1.10-1.22; p < 0.001) but additional adjustment for height completely explained this gender disparity in wait-list mortality (HR 1.05; 95% CI, 0.98-1.12; p = 0.2). Transplantation rates, however, remained lower among females, even after adjustment for height (HR 0.88; 95% CI, 0.82-0.92; p < 0.001). In conclusion, under the current liver allocation system, women have a 19% increased risk of wait-list mortality compared to men with the same MELD scores. Height contributes to this gender disparity, possibly reflecting differences in transplantation rates for shorter individuals.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow of Patients Listed for Liver Transplantation. Abbreviations: HCC, hepatocellular carcinoma; FHF, fulminant hepatic failure; AHN, acute hepatic necrosis; Cr, serum creatinine at listing.
Figure 2
Figure 2
Cumulative incidence curves comparing the risk of wait -list mortality in females compared with males, adjusted for MELD only.
Figure 3
Figure 3
Adjusted Risk of Wait-list Mortality for Females Compared with Males.
Figure 4
Figure 4
Relative Hazard of Wait-List Mortality for Females Compared to Males By A) Creatinine at Listing (mg/dL) and B) GFR at Listing (ml/min).
Figure 5
Figure 5
Height of Female and Male Wait-List Candidates in the United States.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Freeman RB, Jr., Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl. 2002 Sep;8(9):851–8. - PubMed
    1. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000 Apr;31(4):864–71. - PubMed
    1. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001 Feb;33(2):464–70. - PubMed
    1. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl. 2001 Jul;7(7):567–80. - PubMed
    1. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003 Jan;124(1):91–6. - PubMed

Publication types